Pacific Biosciences of California, Inc. (PACB)
USD 1.19
(-6.3%)
USD 1.19
(-6.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 200.52 Million USD | 56.29% |
| 2022 | 128.3 Million USD | -1.69% |
| 2021 | 130.51 Million USD | 65.43% |
| 2020 | 78.89 Million USD | -13.2% |
| 2019 | 90.89 Million USD | 15.6% |
| 2018 | 78.62 Million USD | -15.88% |
| 2017 | 93.46 Million USD | 3.04% |
| 2016 | 90.71 Million USD | -2.23% |
| 2015 | 92.78 Million USD | 53.12% |
| 2014 | 60.59 Million USD | 115.02% |
| 2013 | 28.18 Million USD | 8.46% |
| 2012 | 25.98 Million USD | -23.27% |
| 2011 | 33.86 Million USD | 1922.88% |
| 2010 | 1.67 Million USD | 1140.0% |
| 2009 | 135 Thousand USD | -85.02% |
| 2008 | 901 Thousand USD | -58.34% |
| 2007 | 2.16 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 38.81 Million USD | -33.5% |
| 2024 Q2 | 36.01 Million USD | -7.21% |
| 2023 Q2 | 47.57 Million USD | 22.3% |
| 2023 Q1 | 38.9 Million USD | 42.21% |
| 2023 Q4 | 58.35 Million USD | 4.79% |
| 2023 Q3 | 55.69 Million USD | 17.06% |
| 2023 FY | 200.52 Million USD | 56.29% |
| 2022 Q3 | 32.31 Million USD | -8.9% |
| 2022 Q2 | 35.46 Million USD | 6.92% |
| 2022 Q4 | 27.35 Million USD | -15.34% |
| 2022 FY | 128.3 Million USD | -1.69% |
| 2022 Q1 | 33.17 Million USD | -7.9% |
| 2021 FY | 130.51 Million USD | 65.43% |
| 2021 Q1 | 28.99 Million USD | 6.86% |
| 2021 Q2 | 30.61 Million USD | 5.56% |
| 2021 Q3 | 34.88 Million USD | 13.97% |
| 2021 Q4 | 36.01 Million USD | 3.24% |
| 2020 Q3 | 19.08 Million USD | 11.74% |
| 2020 Q2 | 17.07 Million USD | 9.48% |
| 2020 Q1 | 15.59 Million USD | -44.15% |
| 2020 FY | 78.89 Million USD | -13.2% |
| 2020 Q4 | 27.13 Million USD | 42.21% |
| 2019 FY | 90.89 Million USD | 15.6% |
| 2019 Q1 | 16.42 Million USD | -15.88% |
| 2019 Q2 | 24.62 Million USD | 49.9% |
| 2019 Q3 | 21.91 Million USD | -10.99% |
| 2019 Q4 | 27.93 Million USD | 27.45% |
| 2018 Q3 | 18.16 Million USD | -15.84% |
| 2018 Q1 | 19.36 Million USD | -22.35% |
| 2018 FY | 78.62 Million USD | -15.88% |
| 2018 Q4 | 19.52 Million USD | 7.52% |
| 2018 Q2 | 21.57 Million USD | 11.45% |
| 2017 Q1 | 24.91 Million USD | -3.14% |
| 2017 FY | 93.46 Million USD | 3.04% |
| 2017 Q4 | 24.93 Million USD | 5.9% |
| 2017 Q3 | 23.54 Million USD | 17.3% |
| 2017 Q2 | 20.07 Million USD | -19.43% |
| 2016 Q2 | 20.74 Million USD | 8.47% |
| 2016 Q3 | 25.11 Million USD | 21.07% |
| 2016 Q4 | 25.72 Million USD | 2.4% |
| 2016 FY | 90.71 Million USD | -2.23% |
| 2016 Q1 | 19.12 Million USD | -47.28% |
| 2015 Q4 | 36.28 Million USD | 160.7% |
| 2015 Q1 | 17.64 Million USD | 4.38% |
| 2015 Q2 | 24.93 Million USD | 41.34% |
| 2015 Q3 | 13.91 Million USD | -44.2% |
| 2015 FY | 92.78 Million USD | 53.12% |
| 2014 Q3 | 20.62 Million USD | 80.51% |
| 2014 Q1 | 11.64 Million USD | 27.46% |
| 2014 FY | 60.59 Million USD | 115.02% |
| 2014 Q4 | 16.9 Million USD | -18.03% |
| 2014 Q2 | 11.42 Million USD | -1.86% |
| 2013 Q4 | 9.13 Million USD | 23.08% |
| 2013 Q3 | 7.42 Million USD | 22.7% |
| 2013 Q2 | 6.04 Million USD | 8.43% |
| 2013 Q1 | 5.57 Million USD | -5.1% |
| 2013 FY | 28.18 Million USD | 8.46% |
| 2012 Q1 | 10.03 Million USD | -19.33% |
| 2012 Q2 | 7.29 Million USD | -27.37% |
| 2012 Q4 | 5.87 Million USD | 111.74% |
| 2012 Q3 | 2.77 Million USD | -61.93% |
| 2012 FY | 25.98 Million USD | -23.27% |
| 2011 Q2 | 10.63 Million USD | 3837.04% |
| 2011 Q1 | 270 Thousand USD | -3.57% |
| 2011 FY | 33.86 Million USD | 1922.88% |
| 2011 Q4 | 12.44 Million USD | 18.3% |
| 2011 Q3 | 10.51 Million USD | -1.04% |
| 2010 Q3 | 220 Thousand USD | -65.02% |
| 2010 Q4 | 280 Thousand USD | 27.27% |
| 2010 Q1 | 545 Thousand USD | 303.7% |
| 2010 FY | 1.67 Million USD | 1140.0% |
| 2010 Q2 | 629 Thousand USD | 15.41% |
| 2009 Q4 | 135 Thousand USD | 0.0% |
| 2009 FY | 135 Thousand USD | -85.02% |
| 2009 Q3 | - USD | 0.0% |
| 2008 FY | 901 Thousand USD | -58.34% |
| 2007 FY | 2.16 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -2699.009% |
| Cerus Corporation | 156.36 Million USD | -28.237% |
| OrthoPediatrics Corp. | 148.73 Million USD | -34.82% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -20599.882% |
| Talis Biomedical Corporation | 412 Thousand USD | -48570.146% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -1352.945% |
| Inogen, Inc. | 315.66 Million USD | 36.476% |
| Spectral AI, Inc. | 18.05 Million USD | -1010.551% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -1924.442% |
| CVRx, Inc. | 39.29 Million USD | -410.296% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -31036.801% |
| Orthofix Medical Inc. | 746.64 Million USD | 73.144% |
| Venus Concept Inc. | 76.35 Million USD | -162.62% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -1562.833% |
| Bioventus Inc. | 512.34 Million USD | 60.862% |
| BrainsWay Ltd. | 31.78 Million USD | -530.867% |
| Envoy Medical, Inc. | 316 Thousand USD | -63356.013% |
| electroCore, Inc. | 16.03 Million USD | -1150.911% |
| IceCure Medical Ltd | 3.22 Million USD | -6110.003% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -8158.69% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -54837.411% |
| MaxCyte, Inc. | 41.28 Million USD | -385.664% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -10170.272% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -180960.606% |
| PAVmed Inc | 2.45 Million USD | -8077.855% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -790.453% |
| RxSight, Inc. | 89.07 Million USD | -125.11% |
| Sight Sciences, Inc. | 81.05 Million USD | -147.386% |
| SI-BONE, Inc. | 138.88 Million USD | -44.378% |
| TELA Bio, Inc. | 58.45 Million USD | -243.047% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -983.253% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -7.163% |
| LivaNova PLC | 1.15 Billion USD | 82.617% |
| 908 Devices Inc. | 50.22 Million USD | -299.214% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 58.421% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -260168.158% |
| NeuroPace, Inc. | 65.42 Million USD | -206.509% |
| LENSAR, Inc. | 42.16 Million USD | -375.574% |
| Apyx Medical Corporation | 52.34 Million USD | -283.046% |
| Cutera, Inc. | 212.36 Million USD | 5.579% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -501.118% |
| BioSig Technologies, Inc. | 18 Thousand USD | -1113905.556% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -20.316% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -737.074% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 86.992% |
| Axonics, Inc. | 366.37 Million USD | 45.27% |
| Outset Medical, Inc. | 130.37 Million USD | -53.802% |
| IRIDEX Corporation | 51.86 Million USD | -286.591% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -47.235% |
| IRadimed Corporation | 65.56 Million USD | -205.848% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -16951.105% |
| INVO Bioscience, Inc. | 3.02 Million USD | -6538.504% |
| Telesis Bio, Inc. | 27.5 Million USD | -628.929% |
| Viemed Healthcare, Inc. | 183 Million USD | -9.57% |
| Varex Imaging Corporation | 811 Million USD | 75.275% |
| Quipt Home Medical Corp. | 221.74 Million USD | 9.57% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -191.985% |
| Dynatronics Corporation | 32.53 Million USD | -516.344% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -2210.682% |
| Semler Scientific, Inc. | 68.18 Million USD | -194.088% |
| InMode Ltd. | 492.04 Million USD | 59.248% |
| Bruker Corporation | 2.96 Billion USD | 93.236% |
| Cytosorbents Corporation | 36.34 Million USD | -451.649% |
| DexCom, Inc. | 3.62 Billion USD | 94.464% |
| Align Technology, Inc. | 3.86 Billion USD | 94.808% |
| Viveve Medical, Inc. | 6.42 Million USD | -3020.464% |
| ZimVie Inc. | 457.43 Million USD | 56.164% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -3.889% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -180960.606% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 73.182% |
| Profound Medical Corp. | 7.33 Million USD | -2635.24% |
| Insulet Corporation | 1.69 Billion USD | 88.184% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -59.045% |
| iCAD, Inc. | 17.31 Million USD | -1057.876% |
| Nuwellis, Inc. | 8.86 Million USD | -2162.195% |
| Biotricity, Inc. | 12.06 Million USD | -1562.234% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 59.3% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -3131.604% |
| PAVmed Inc. | 2.45 Million USD | -8077.855% |
| BIOLASE, Inc. | 49.16 Million USD | -307.861% |
| Beyond Air, Inc. | 1.15 Million USD | -17201.208% |
| FONAR Corporation | 102.88 Million USD | -94.9% |
| AxoGen, Inc. | 159.01 Million USD | -26.104% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 26.93% |
| Inari Medical, Inc. | 493.63 Million USD | 59.378% |
| UFP Technologies, Inc. | 400.07 Million USD | 49.879% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -1077969.892% |
| Tenon Medical, Inc. | 2.92 Million USD | -6748.395% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -2843.627% |
| AdaptHealth Corp. | 3.2 Billion USD | 93.734% |
| Sintx Technologies, Inc. | 2.62 Million USD | -7533.08% |
| NanoVibronix, Inc. | 2.28 Million USD | -8683.224% |
| Quanterix Corporation | 122.36 Million USD | -63.867% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -721.639% |
| TransMedics Group, Inc. | 241.62 Million USD | 17.011% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -1347.387% |
| NeuroMetrix, Inc. | 5.9 Million USD | -3297.84% |
| Hyperfine, Inc. | 11.03 Million USD | -1717.631% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -21.417% |
| Biomerica, Inc. | 5.41 Million USD | -3603.066% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -296.592% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -13.203% |